Global Source Ventures - aVenture Asset Manager Research
Location
San Diego, CA, US
Founded
2011
Global Source Ventures focuses on early-stage life sciences companies with disruptive technologies in healthcare and sustainability. They provide capital, management, and advisory services to portfolio companies. Their typical investment rounds include Series A and Series B, though specific investment sizes are not disclosed.
The firm leverages an international network of investors, investment bankers, financial analysts, scientific experts, and industry contacts. Notable portfolio companies include Oncternal Therapeutics, Selection Therapeutics, and VelosBio. Global Source Ventures' managing partners have a track record of securing funding, setting strategy, and building successful organizations in the life sciences sector.
Global Source Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count2
Total Portfolio Exits1
Top Investment Stages
Series B2 (66.7%)
Series A1 (33.3%)
Stage Mix
Series B 67%Series A 33%
Concentration shown as share of disclosed investments by stage.
